LILRB5: A Protein with Potential as A Drug Target Or Biomarker

Target Name: LILRB5

NCBI ID: G10990

LILRB5

LILRB5: A Protein with Potential as A Drug Target Or Biomarker

LILRB5 (Leukocyte immunoglobulin-like receptor subfamily B member 5) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and skin. It is a member of the Leukocyte immunoglobulin-like receptor subfamily B (LIRGB) and is responsible for cell signaling and immune responses.

Recent studies have suggested that LILRB5 may have potential as a drug target or biomarker. One of the main reasons for this is the fact that LILRB5 is involved in the regulation of immune cell function and has been shown to play a role in the development of autoimmune diseases. Additionally, LILRB5 has also been shown to be involved in the regulation of inflammation, which could make it a potential target for treatments for inflammatory diseases.

Another potential mechanism by which LILRB5 may be involved in drug targeting is through its role in cell signaling. LILRB5 is a G protein-coupled receptor (GPCR), which means that it interacts with intracellular signaling molecules to regulate cellular behavior. Recent studies have shown that LILRB5 can interact with the protein Pyh0, which is a negative regulator of the T-cell receptor. This interaction between LILRB5 and Pyh0 suggests that LILRB5 may be a potential drug target for T-cell-related diseases.

In addition to its potential role as a drug target, LILRB5 has also been shown to be a potential biomarker for various diseases. For example, LILRB5 has been shown to be involved in the regulation of skin barrier function, which could make it a potential biomarker for skin disorders. Additionally, LILRB5 has also been shown to be involved in the regulation of inflammation, which could make it a potential biomarker for inflammatory diseases such as rheumatoid arthritis.

Another potential application of LILRB5 as a biomarker is its role in the regulation of cancer cell growth. LILRB5 has been shown to be involved in the regulation of cell cycle progression and has been shown to play a role in the development of cancer. This suggests that LILRB5 may be a potential biomarker for cancer and that its levels may be useful as a diagnostic marker for cancer.

In conclusion, LILRB5 is a protein that has been shown to be involved in the regulation of various cellular processes in the body. Its potential as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of LILRB5 in cell signaling and immune responses, as well as its potential as a drug target or biomarker.

Protein Name: Leukocyte Immunoglobulin Like Receptor B5

Functions: May act as receptor for class I MHC antigens

The "LILRB5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LILRB5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets